$CGON
CG Oncology, Inc. Common stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$62.00
▼-0.86%-$0.540
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCG Oncology, Inc. Common stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CGON down today? It is at $62.00 (-0.86%), and our scanner flagged it 77 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CGON spikes, and full due diligence on CGON — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CGON 77 times in the last 30 days. Create a free account to track $CGON, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CGON from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CGON today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystCG Oncology, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 19, 2026 · 6 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
7,594,587 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $550.0M in size · Priced at $72.42/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Post Leonard E Director | Sold (automatic/other) | -1K | n/a | n/a | $62K at $61.65 | Oct 15, 26 |
Post Leonard E Director | Other | 1K | n/a | 1K | $600 at $0.600 | Oct 15, 26 |
Post Leonard E Director | Sold (automatic/other) | -1K | n/a | n/a | $73K at $72.98 | Sep 15, 26 |
Post Leonard E Director | Other | 1K | n/a | 1K | $600 at $0.600 | Sep 15, 26 |
Post Leonard E Director | Sold (automatic/other) | -1K | n/a | n/a | $75K at $74.54 | Aug 14, 26 |
Post Leonard E Director | Other | 1K | n/a | 1K | $600 at $0.600 | Aug 14, 26 |
Post Leonard E Director | Sold (automatic/other) | -1K | n/a | n/a | $71K at $71.17 | Jul 15, 26 |
Post Leonard E Director | Other | 1K | n/a | 1K | $600 at $0.600 | Jul 15, 26 |
Mulay James Director | Sold (automatic/other) | -24K 0.03% of company | n/a | n/a | $1.8M at $75.16 | Jul 10, 26 |
Mulay James Director | Other | 24K 0.03% of company | n/a | 24K | $644K at $26.63 | Jul 10, 26 |
Liu Brian Guan-Chyun Director | Bought (open market) | +371K 0.4% of company | added 24% | 1.89M | $24.8M at $66.87 | Jun 25, 26 |
Post Leonard E Director | Sold (automatic/other) | -5K | n/a | n/a | $350K at $70.00 | Jun 24, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CGON from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CGON today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CGON last traded at $62.00, down 0.86% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
CG Oncology, Inc. Common stock (CGON) is next expected to report earnings on Friday, November 13, 2026, about 19 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CGON Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CGON 77 times in the last 30 days.
CGON (CG Oncology, Inc. Common stock) trades on XNAS, with a market cap of about $5.47B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CGON for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CGON discussion
Sign in to ask a question or join the discussion.